Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (688)	2/21/2000 6:54:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 52153

"GLIA is clearly a munch candidate" Would you explain why you think so - merely because of the price or do you think the Adcon line would hold particular interest for someone (besides GZSP)?

To: Biomaven who wrote (688)	2/21/2000 7:54:00 PM
From: Torben Noerup Nielsen	Respond to of 52153

Peter, I certainly wouldn't opt to be re-opened for an application of ADCON if that were the question.... :-) But I've looked at the technology too and as far as I can tell, ADCON is superior to Seprafilm. Moreover, I think the Gliatech pipeline is way undervalued. There are some potential gems in there. Add to that all the proprietary knowledge they've built up on glial cells. The people count for something too. Insert Cato paraphrase. Thanks, Torben